BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr 2010;169:7-13. [PMID: 19707787 DOI: 10.1007/s00431-009-1039-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang M. Synthetic host molecules and sequestrants as therapeutic agents. Drug Discovery Today: Technologies 2010;7:e131-7. [DOI: 10.1016/j.ddtec.2010.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Davis TK, Hmiel P. Pediatric Hematuria Remains a Clinical Dilemma. Clin Pediatr (Phila) 2015;54:817-30. [PMID: 25253774 DOI: 10.1177/0009922814551137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Lei TH, Hsia SH, Wu CT, Lin JJ. Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection. Eur J Pediatr 2010;169:237-9. [PMID: 19908065 DOI: 10.1007/s00431-009-1081-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
4 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study. Pediatr Nephrol 2015;30:339-44. [PMID: 25138373 DOI: 10.1007/s00467-014-2911-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Teoh CW, Riedl M, Licht C. The alternative pathway of complement and the thrombotic microangiopathies. Transfus Apher Sci. 2016;54:220-231. [PMID: 27160864 DOI: 10.1016/j.transci.2016.04.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
6 Kreuzer M, Sollmann L, Ruben S, Leifheit-nestler M, Fischer D, Pape L, Haffner D. Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome. Pediatr Nephrol 2017;32:1005-11. [DOI: 10.1007/s00467-016-3574-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 van Hoeve K, Vandermeulen C, Van Ranst M, Levtchenko E, van den Heuvel L, Mekahli D. Occurrence of atypical HUS associated with influenza B. Eur J Pediatr 2017;176:449-54. [PMID: 28110418 DOI: 10.1007/s00431-017-2856-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
8 da Silva PSL, Lipinski RW. Hemolytic uremic syndrome associated with Acinetobacter hemolyticus. Renal Failure 2014;36:1122-4. [DOI: 10.3109/0886022x.2014.917575] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Amouroux C, Adra AL, Mouba JF, Tenenbaum J, Ichay L, Dalla-Vale F, Milesi C, Morin D. [Hemolytic uremic syndrome with severe neurological involvement: how should it be managed?]. Arch Pediatr 2012;19:150-5. [PMID: 22245485 DOI: 10.1016/j.arcped.2011.11.015] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56-76 [PMID: 24255888 DOI: 10.5527/wjn.v2.i3.56] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
11 Lopes da Silva R. Viral-associated thrombotic microangiopathies. Hematol Oncol Stem Cell Ther 2011;4:51-9. [PMID: 21727765 DOI: 10.5144/1658-3876.2011.51] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
12 Buder K, Latal B, Nef S, Neuhaus TJ, Laube GF, Spartà G. Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome. Pediatr Nephrol 2015;30:503-13. [PMID: 25234636 DOI: 10.1007/s00467-014-2950-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
13 Keir LS, Saleem MA. Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol 2014;29:1895-902. [PMID: 23843163 DOI: 10.1007/s00467-013-2561-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ko EY, Kim JY, Lee HJ, Lee HS, Han JW, Kim YH, Kim JT, Cheong HI, Jang PS. A case of hemolytic uremic syndrome preceded by intussusception. Korean J Pediatr 2011;54:176-8. [PMID: 21738552 DOI: 10.3345/kjp.2011.54.4.176] [Reference Citation Analysis]
15 Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012;55:753-9. [PMID: 22670043 DOI: 10.1093/cid/cis531] [Cited by in Crossref: 100] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
16 Seltz LB, Bakel LA, Tiehen J, Gao D, Cadnapaphornchai MA, Lum G, Ford D. Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome. Thromb Res 2012;130:e26-30. [PMID: 22683020 DOI: 10.1016/j.thromres.2012.05.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Woo da E, Lee JM, Kim YK, Park YH. Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome. Korean J Pediatr 2016;59:100-3. [PMID: 26958070 DOI: 10.3345/kjp.2016.59.2.100] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Davin JC, van de Kar NC. Advances and challenges in the management of complement-mediated thrombotic microangiopathies. Ther Adv Hematol 2015;6:171-85. [PMID: 26288712 DOI: 10.1177/2040620715577613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
19 Bajracharya P, Jain A, Baracco R, Mattoo TK, Kapur G. Atypical hemolytic uremic syndrome: a clinical conundrum. Pediatr Nephrol 2016;31:1615-24. [PMID: 27139899 DOI: 10.1007/s00467-016-3369-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
20 Adragna M, Balestracci A, García Chervo L, Steinbrun S, Delgado N, Briones L. Acute dialysis-associated peritonitis in children with D+ hemolytic uremic syndrome. Pediatr Nephrol 2012;27:637-42. [DOI: 10.1007/s00467-011-2027-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T. Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement. Medicine (Baltimore) 2015;94:e1000. [PMID: 26091445 DOI: 10.1097/MD.0000000000001000] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
22 Avcı Z, Bayram C, Malbora B. Hepatitis B vaccine-associated atypical hemolytic uremic syndrome. Turk J Haematol 2013;30:418-9. [PMID: 24385836 DOI: 10.4274/Tjh-2013.0226] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Janapatla RP, Hsu MH, Liao WT, Chien KY, Lee HY, Chiu CH. Low Serum Fetuin-A as a Biomarker to Predict Pneumococcal Necrotizing Pneumonia and Hemolytic Uremic Syndrome in Children. Medicine (Baltimore) 2016;95:e3221. [PMID: 27043691 DOI: 10.1097/MD.0000000000003221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012;345:e4565. [PMID: 22815429 DOI: 10.1136/bmj.e4565] [Cited by in Crossref: 203] [Cited by in F6Publishing: 164] [Article Influence: 20.3] [Reference Citation Analysis]
25 Magro CM, Wang X. Cocaine-associated retiform purpura: a C5b-9-mediated microangiopathy syndrome associated with enhanced apoptosis and high levels of intercellular adhesion molecule-1 expression. Am J Dermatopathol 2013;35:722-30. [PMID: 23392134 DOI: 10.1097/DAD.0b013e31827eaf0b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
26 Vind AC, Snieckute G, Blasius M, Tiedje C, Krogh N, Bekker-Jensen DB, Andersen KL, Nordgaard C, Tollenaere MAX, Lund AH, Olsen JV, Nielsen H, Bekker-Jensen S. ZAKα Recognizes Stalled Ribosomes through Partially Redundant Sensor Domains. Mol Cell 2020;78:700-713.e7. [PMID: 32289254 DOI: 10.1016/j.molcel.2020.03.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
27 Mittal N, Hartemayer R, Jandeska S, Giordano L. Steroid Responsive Atypical Hemolytic Uremic Syndrome Triggered by Influenza B Infection. J Pediatr Hematol Oncol 2019;41:e63-7. [PMID: 29702545 DOI: 10.1097/MPH.0000000000001180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Pipili C, Pantelias K, Papaioannou N, Paraskevakou H, Grapsa E. Hemolytic-uremic syndrome, malignant hypertension and IgA nephropathy: successful treatment with plasma exchange therapy. Transfus Apher Sci 2012;47:155-8. [PMID: 22892290 DOI: 10.1016/j.transci.2012.06.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Riedl M, Rosales A, Zimmerhackl LB, Jungraithmayr T. Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H: Editorial. Pediatric Transplantation 2011;15:225-8. [DOI: 10.1111/j.1399-3046.2010.01345.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Oualha M, Pierrepont S, Krug P, Gitiaux C, Hubert P, Lesage F, Salomon R. Postdiarrheal hemolytic and uremic syndrome with severe multiorgan involvement and associated early risk factors. Arch Pediatr 2018;25:118-25. [PMID: 29395881 DOI: 10.1016/j.arcped.2017.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. BMC Infect Dis 2016;16:285. [PMID: 27297224 DOI: 10.1186/s12879-016-1627-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
32 Kusztrich A, Garten L, Hüseman D, Bührer C. Hemolytic uremic syndrome in a preterm infant. Pediatr Nephrol 2010;25:987-8. [DOI: 10.1007/s00467-009-1395-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Janapatla RP, Hsu MH, Hsieh YC, Lee HY, Lin TY, Chiu CH. Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children. Clin Microbiol Infect 2013;19:480-6. [PMID: 22591179 DOI: 10.1111/j.1469-0691.2012.03894.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
34 Koppula S, Yost SE, Sussman A, Bracamonte ER, Kaplan B. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients. Clin Transplant. 2013;27:591-597. [PMID: 23923969 DOI: 10.1111/ctr.12170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
35 Bauer A, Loos S, Wehrmann C, Horstmann D, Donnerstag F, Lemke J, Hillebrand G, Löbel U, Pape L, Haffner D, Bindt C, Ahlenstiel T, Melk A, Lehnhardt A, Kemper MJ, Oh J, Hartmann H. Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol 2014;29:1607-15. [PMID: 24664191 DOI: 10.1007/s00467-014-2803-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
36 Prohászka Z, Varga L, Füst G. The use of ‘real-time’ complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies. Br J Haematol 2012;158:424-5. [DOI: 10.1111/j.1365-2141.2012.09168.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
37 Mukai S, Hidaka Y, Hirota-kawadobora M, Matsuda K, Fujihara N, Takezawa Y, Kubota S, Koike K, Honda T, Yamauchi K. Factor H gene variants in Japanese: Its relation to atypical hemolytic uremic syndrome. Molecular Immunology 2011;49:48-55. [DOI: 10.1016/j.molimm.2011.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Vester U, Mache CJ. Pharmacological treatment of atypical hemolytic-uremic syndrome. Expert Opinion on Orphan Drugs 2014;2:123-35. [DOI: 10.1517/21678707.2014.872029] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Baweja S, Wiggins K, Lee D, Blair S, Fraenkel M, Mcmahon LP. Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach. J Artif Organs 2011;14:9-22. [DOI: 10.1007/s10047-010-0529-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
40 Bernedo-Navarro RA, Miyachiro MM, da Silva MJ, Reis CF, Conceição RA, Gatti MS, Yano T. Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicity in vitro and in vivo. J Appl Microbiol 2014;116:1322-33. [PMID: 24447276 DOI: 10.1111/jam.12451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
41 Nicolay JP, Thorn V, Daniel C, Amann K, Siraskar B, Lang F, Hillgruber C, Goerge T, Hoffmann S, Gorzelanny C, Huck V, Mess C, Obser T, Schneppenheim R, Fleming I, Schneider MF, Schneider SW. Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy. Sci Rep 2018;8:10945. [PMID: 30026593 DOI: 10.1038/s41598-018-28961-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
42 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 2012;27:1407-10. [PMID: 22476204 DOI: 10.1007/s00467-012-2158-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
43 Huzmeli C, Candan F, Seker A, Yildiz E, Terzi H, Kayatas M. C3 mesangial proliferative glomerulonephritis initially presenting with atypical hemolytic uremic syndrome: a case report. J Med Case Rep 2016;10:206. [PMID: 27460033 DOI: 10.1186/s13256-016-0992-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
44 Ardissino G, Testa S, Possenti I, Tel F, Paglialonga F, Salardi S, Tedeschi S, Belingheri M, Cugno M. Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases. Am J Kidney Dis. 2014;64:633-737. [PMID: 24656451 DOI: 10.1053/j.ajkd.2014.01.434] [Cited by in Crossref: 132] [Cited by in F6Publishing: 106] [Article Influence: 16.5] [Reference Citation Analysis]
45 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Laboratory predictors of acute dialysis in hemolytic uremic syndrome. Pediatr Int 2014;56:234-9. [PMID: 24266872 DOI: 10.1111/ped.12245] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
46 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 2013;28:919-25. [PMID: 23386110 DOI: 10.1007/s00467-013-2414-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
47 Blake-Haskins JA, Lechleider RJ, Kreitman RJ. Thrombotic microangiopathy with targeted cancer agents. Clin Cancer Res 2011;17:5858-66. [PMID: 21813634 DOI: 10.1158/1078-0432.CCR-11-0804] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
48 Lee CS, Chen MJ, Chiou YH, Shen CF, Wu CY, Chiou YY. Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan.Nephrology (Carlton). 2012;17:48-52. [PMID: 21777347 DOI: 10.1111/j.1440-1797.2011.01500.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
49 Saini A, Emke AR, Silva MC, Perlman SJ. Response to Eculizumab in Escherichia coli O157: H7–Induced Hemolytic Uremic Syndrome With Severe Neurological Manifestations. Clin Pediatr (Phila) 2015;54:387-9. [DOI: 10.1177/0009922814534520] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
50 Devakumar D, Kitching A, Zenner D, Tostmann A, Meltzer M. Tracking sickness through social networks - the practical use of social network mapping in supporting the management of an E. coli O157 outbreak in a primary school in London. Epidemiol Infect 2013;141:2022-30. [PMID: 23445786 DOI: 10.1017/S0950268813000344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol 2020;35:1749-59. [PMID: 32323005 DOI: 10.1007/s00467-020-04560-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
52 Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011;6:60. [PMID: 21902819 DOI: 10.1186/1750-1172-6-60] [Cited by in Crossref: 375] [Cited by in F6Publishing: 304] [Article Influence: 34.1] [Reference Citation Analysis]
53 Printza N, Roilides E, Kotsiou M, Zafeiriou D, Hatzidimitriou V, Papachristou F. Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome. Pediatr Nephrol 2011;26:143-4. [DOI: 10.1007/s00467-010-1603-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
54 Webster K, Schnitzler E. Hemolytic uremic syndrome. Handb Clin Neurol 2014;120:1113-23. [PMID: 24365375 DOI: 10.1016/B978-0-7020-4087-0.00075-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
55 Weiss A, Schmidt H, Stöber H. Mechanisms of enterohemorrhagic Escherichia coli spread along the food-chain and precautionary measures. J Verbr Lebensm 2011;6:503-10. [DOI: 10.1007/s00003-011-0736-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
56 Mallick EM, McBee ME, Vanguri VK, Melton-Celsa AR, Schlieper K, Karalius BJ, O'Brien AD, Butterton JR, Leong JM, Schauer DB. A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest 2012;122:4012-24. [PMID: 23041631 DOI: 10.1172/JCI62746] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
57 Thévenot J, Cordonnier C, Rougeron A, Le Goff O, Nguyen HT, Denis S, Alric M, Livrelli V, Blanquet-Diot S. Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer's patches. Appl Microbiol Biotechnol 2015;99:9097-110. [PMID: 26084888 DOI: 10.1007/s00253-015-6704-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
58 Zlamy M, Hofer J, Elias J, Vogel U, Frosch M, Jungraithmayr T, Zimmerhackl LB, Prelog M. Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. Pediatr Transplant 2012;16:E246-50. [PMID: 21967634 DOI: 10.1111/j.1399-3046.2011.01585.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
59 Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26:41-57. [PMID: 20556434 DOI: 10.1007/s00467-010-1556-4] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
60 Reusz G, Szabó A, Réti M, Györke Z, Szilágyi Á, Farkas P, Prohászka Z. Diagnosis and Classification of Hemolytic Uremic Syndrome: The Hungarian Experience. Transplantation Proceedings 2011;43:1247-9. [DOI: 10.1016/j.transproceed.2011.03.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 2012;8:658-69. [PMID: 22986362 DOI: 10.1038/nrneph.2012.196] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
62 Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens 2010;19:242-7. [PMID: 20186056 DOI: 10.1097/MNH.0b013e3283378f25] [Cited by in Crossref: 62] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
63 Büyükçelik M, Keskin M, Keskin Ö, Bay A, Kılıç BD, Kor Y, Kılınç MA, Balat A. Autoimmune polyglandular syndrome type 3c with ectodermal dysplasia, immune deficiency and hemolytic-uremic syndrome. J Clin Res Pediatr Endocrinol 2014;6:47-50. [PMID: 24637310 DOI: 10.4274/Jcrpe.1128] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Favier GI, Lucero Estrada C, Cortiñas TI, Escudero ME. Detection and Characterization of Shiga Toxin Producing Escherichia coli, Salmonella spp., and Yersinia Strains from Human, Animal, and Food Samples in San Luis, Argentina. Int J Microbiol 2014;2014:284649. [PMID: 25177351 DOI: 10.1155/2014/284649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
65 Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab. Pediatr Nephrol 2013;28:155-8. [PMID: 22956028 DOI: 10.1007/s00467-012-2296-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
66 Janapatla RP, Chen CL, Hsu MH, Liao WT, Chiu CH. Immunization with pneumococcal neuraminidases NanA, NanB and NanC to generate neutralizing antibodies and to increase survival in mice. J Med Microbiol 2018;67:709-23. [PMID: 29557769 DOI: 10.1099/jmm.0.000724] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
67 Rusai K, Gruber K, Dufek S, Seidl R, Arbeiter K, Aufricht C, Mueller-Sacherer T. Late-onset neurological symptoms in a child with diarrhea-associated hemolytic uremic syndrome. Ther Apher Dial 2015;19:192-4. [PMID: 25363791 DOI: 10.1111/1744-9987.12243] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Balestracci A, Toledo I, Meni Battaglia L, de Lillo L, More N, Cao G, Alvarado C. Postdiarrhoeal haemolytic uraemic syndrome without thrombocytopenia. Nefrologia 2017;37:508-14. [PMID: 28946963 DOI: 10.1016/j.nefro.2016.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
69 Borkar D, Schutt C, Verghese P. Renal Recovery Years After Initial Diagnosis of Hemolytic Uremic Syndrome. Clin Pediatr (Phila) 2018;57:861-4. [PMID: 28931327 DOI: 10.1177/0009922817732621] [Reference Citation Analysis]
70 Detzner J, Pohlentz G, Müthing J. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome. Toxins (Basel) 2020;12:E373. [PMID: 32512916 DOI: 10.3390/toxins12060373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]